{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:18:39Z","timestamp":1791069519566,"version":"4.1.0"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2004,5,25]],"date-time":"2004-05-25T00:00:00Z","timestamp":1085443200000},"content-version":"vor","delay-in-days":1546,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biometrics"],"published-print":{"date-parts":[[2000,3]]},"abstract":"<jats:p><jats:bold>Summary. <\/jats:bold> The Quality\u2010Adjusted Time Without Symptoms or Toxicity (Q\u2010TWiST) statistic previously introduced by Glasziou, Simes and Gelber (1990, <jats:italic>Statistics in Medicine<\/jats:italic><jats:bold>9<\/jats:bold>, 1259\u20131276) combines toxicity, disease\u2010free survival, and overall survival information in assessing the impact of treatments on the lives of patients. This methodology has received positive reviews from clinicians as intuitive and useful, but to date, the variance of this statistic has remained unspecified. We review aspects of the Q\u2010TWiST method for analyzing clinical trial data, extend the method to accommodate multiple treatment arms, and provide closed\u2010form asymptotic variance formulas. We also provide a framework for designing Q\u2010TWiST clinical trials with sample sizes determined using the derived asymptotic variance formulas. Trials currently collecting quality of life data did not have the benefit of these sample size calculation techniques in designing their studies.<\/jats:p>","DOI":"10.1111\/j.0006-341x.2000.00173.x","type":"journal-article","created":{"date-parts":[[2004,5,25]],"date-time":"2004-05-25T08:45:47Z","timestamp":1085474747000},"page":"173-182","source":"Crossref","is-referenced-by-count":22,"title":["Variance and Sample Size Calculations in Quality\u2010of\u2010Life\u2010Adjusted Survival Analysis (Q\u2010TWiST)"],"prefix":"10.1093","volume":"56","author":[{"given":"Susan","family":"Murray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2004,5,25]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4612-4348-9"},{"key":"e_1_2_1_3_1","volume-title":"Mathematical Statistics: Basic Ideas and Selected Topics","author":"Bickel P. J.","year":"1977"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1214\/aos\/1176342705"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780121009"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.2307\/2532777"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.10.2666"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1214\/aos\/1176351049"},{"key":"e_1_2_1_9_1","volume-title":"Counting Processes and Survival Analysis","author":"Fleming T. R.","year":"1991"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-114-8-621"},{"key":"e_1_2_1_11_1","first-page":"127","article-title":"Quality of life in clinical trials of adjuvant therapies","volume":"11","author":"Gelber R. D.","year":"1992","journal-title":"Journal of the National Cancer Institute Monographs"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-116-12-961"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.2307\/2684631"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/88.15.1039"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780091106"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199403173301102"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198809153191104"},{"key":"e_1_2_1_18_1","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1200\/JCO.1991.9.12.2225","article-title":"Commentary concerning demonstration of safety and efficacy of investigational anticancer agents in clinical trials","volume":"9","author":"O'Shaughnessy J. A.","year":"1991","journal-title":"Journal of Clinical Oncology"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/79.3.495"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1984.10478093"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-842X.1988.tb00628.x"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/biomet\/84.2.339"}],"container-title":["Biometrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.0006-341X.2000.00173.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.0006-341X.2000.00173.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T18:18:15Z","timestamp":1706293095000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biometrics\/article\/56\/1\/173-182\/7263401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["10.1111\/j.0006-341X.2000.00173.x"],"URL":"https:\/\/doi.org\/10.1111\/j.0006-341x.2000.00173.x","archive":["Portico"],"relation":{},"ISSN":["0006-341X","1541-0420"],"issn-type":[{"value":"0006-341X","type":"print"},{"value":"1541-0420","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}